Joshua Laber

Joshua Laber has a diverse work experience in the field of formulation development and biologics product development. Joshua currently holds the position of Senior Scientist at Sutro Biopharma, Inc., where they are involved in formulation development. Prior to that, they worked at Nektar Therapeutics as a Scientist 2, focusing on formulation and biologics product development.

Joshua also gained valuable experience at BioMarin Pharmaceutical Inc., where they held the roles of Scientist 2 and Scientist 1 in formulation. In these positions, they led efforts to develop and test novel peptide formulations, presented results at cross-functional meetings, and developed new testing and dosing methods.

Before joining BioMarin, Joshua worked as a Postdoctoral Fellow at AbbVie, where they conducted research on the immunogenicity of monoclonal antibody aggregates and explored interactions between antibodies to improve candidate selection. Joshua conducted physicochemical and biophysical characterization of antibodies and studied their responses to manufacturing stressors.

Joshua's academic background includes a Ph.D. in Chemical Engineering from the University of Texas at Austin, where they focused on the biophysical, biochemical, and immunological consequences of high-concentration drug delivery of protein therapeutics. Joshua conducted research on the effect of surface charge on subcutaneous protein therapeutic delivery and investigated the interactions of monoclonal antibodies to understand their thermal stability and self-interaction propensity.

Furthermore, Joshua gained experience through various roles during their undergraduate years. Joshua was an Associate at Texas Venture Labs, an Activities Coordinator at the American Institute of Chemical Engineers (AIChE), UC Berkeley Chapter, and an Undergraduate Researcher at the Clark/Blanch Lab, University of California, Berkeley, and the BATT Program, Lawrence Berkeley National Laboratory.

Overall, Joshua Laber's work experience demonstrates their expertise in formulation development, biologics product development, and the characterization of protein therapeutics.

Joshua Laber received their Bachelor of Science (B.S.) degree in Chemical Engineering from the University of California, Berkeley, where they studied from 2007 to 2011. Joshua then pursued further education at The University of Texas at Austin, where they obtained a Master of Science in Engineering (M.S.E.) in Chemical Engineering from 2011 to 2013. Subsequently, they continued their studies at The University of Texas at Austin and earned their Doctor of Philosophy (Ph.D.) degree in Chemical Engineering from 2011 to 2016.